Exploring the Potentials of Silver Nanoparticles in Overcoming Cisplatin Resistance in Lung Adenocarcinoma: Insights from Proteomic and Xenograft Mice Studies. [PDF]
ACS NanoWong TY +11 more
europepmc +1 more source
Cochlear damage by Nitromin or Cisplatin and its influence of steroid hormone.
, 1986 Kazuhiko Kawade +2 more
openalex +2 more sources
Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony- stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin [see comments] [PDF]
, 1992 W Brugger +6 more
openalex +1 more source
Animal Models and Experimental Medicine, EarlyView.Optimized lidocaine‐loaded PLGA non‐spherical particles (LPNMs) and dexamethasone microcrystals (DEX MCs) were prepared. They were then mixed in sodium hyaluronate solution to obtain a co‐delivery system, administrated in guinea pigs to evaluate the pharmacokinetics and biocompatibility of the system.
Dongcheng Wang +7 more
wiley +1 more source
LncPRESS1 promotes the progression and cisplatin resistance of breast cancer through upregulation of ENO1 and activation of glycolysis. [PDF]
Cell DivKe L +7 more
europepmc +1 more source
Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin [PDF]
, 1990 R. Gerritsen van der Hoop +4 more
openalex +1 more source
Chemoembolization with cisplatin-microcapsule.
, 1985 Yoshitaka Okamoto +6 more
openalex +2 more sources
Ulinastatin protects against cisplatin-induced ovarian damage via Nrf2/Keap1 pathway. [PDF]
J Ovarian ResZhao L, Wu Y, Zhang X, Li Y, Li Y, Fu Z.
europepmc +1 more source